
    
      To evaluate the safety and tolerability of the SCNT-hES-RPEs, to assess the number of
      SCNT-hES-RPE cells to be transplanted in future studies and to evaluate on an exploratory
      basis potential efficacy endpoints to be used in future studies of SCNT-hES-RPE cellular
      therapy.
    
  